Xenocor announced that it received FDA clearance for its Xenoscope disposable 5mm articulating laparoscope for abdominal and thoracic surgery.
The Salt Lake City-based company designed its latest laparoscope to improve image quality, reduce fog, lower hospital costs and reduce bio-hazard risk for the patient and staff.
Xenocor’s new Xenoscope includes a disposable 5mm camera on a rigid shaft with a 900 articulating tip with a low-cost compact reusable Xenobox video processor. The designed the video processor so that images can be displayed on any HD monitor or on a hospital’s existing tower system.
Clinicians are able to dispose of the Xenoscope after each procedure to reduce patient and staff biohazard risk, while the reduced fog helps to improve patient care while it reduces procedure time and costs, according to a news release.
The articulating Xenoscope is indicated for use in diagnostic and therapeutic procedures for endoscopy and endoscopic surgery within the thoracic and peritoneal cavities, including female reproductive organs.
“The Xenoscope does not require large up-front capital equipment expenditures,” Xenocor CEO Evan Kelso said in the release. “Xenoscopes have sophisticated image processors for consistent image quality but are still easy to use with universal ‘plug-and-play’ functionality. With a single-use instrument, we can help reduce patient and staff contamination risks due to a dirty scope or incorrect processing. Patients win and hospitals win.”
